These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15917567)

  • 1. In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus.
    Lass-Flörl C; Rief A; Leitner S; Speth C; Würzner R; Dierich MP
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2539-40. PubMed ID: 15917567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN;
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.
    Meletiadis J; Antachopoulos C; Stergiopoulou T; Pournaras S; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3329-37. PubMed ID: 17576838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.
    Sutton DA; Sanche SE; Revankar SG; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1999 Jul; 37(7):2343-5. PubMed ID: 10364610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex.
    Salas V; Pastor FJ; Sutton DA; Calvo E; Mayayo E; Fothergill AW; Rinaldi MG; Guarro J
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1532-4. PubMed ID: 23295929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro.
    Perkhofer S; Lugger H; Dierich MP; Lass-Flörl C
    Antimicrob Agents Chemother; 2007 Feb; 51(2):791-3. PubMed ID: 17116665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.
    Wetter TJ; Hazen KC; Cutler JE
    Med Mycol; 2005 Sep; 43(6):525-32. PubMed ID: 16323310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.
    Oakley KL; Moore CB; Denning DW
    J Antimicrob Chemother; 1998 Jul; 42(1):91-4. PubMed ID: 9700534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method].
    García-Martos P; García-Agudo L; Gutiérrez-Calzada J; Ruiz-Aragón J; Saldarreaga A; Marín P
    Enferm Infecc Microbiol Clin; 2005 Jan; 23(1):15-8. PubMed ID: 15701327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
    Gomez-Lopez A; Garcia-Effron G; Mellado E; Monzon A; Rodriguez-Tudela JL; Cuenca-Estrella M
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3085-8. PubMed ID: 14506013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
    Arikan S; Lozano-Chiu M; Paetznick V; Nangia S; Rex JH
    J Clin Microbiol; 1999 Dec; 37(12):3946-51. PubMed ID: 10565912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
    Meletiadis J; Al-Saigh R; Velegraki A; Walsh TJ; Roilides E; Zerva L
    Antimicrob Agents Chemother; 2012 Jan; 56(1):403-10. PubMed ID: 22064546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M; Rodríguez-Tudela JL; Mellado E; Martínez-Suárez JV; Monzón A
    J Antimicrob Chemother; 1998 Oct; 42(4):531-3. PubMed ID: 9818755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.
    Elefanti A; Mouton JW; Verweij PE; Tsakris A; Zerva L; Meletiadis J
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4656-63. PubMed ID: 23856768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD; Kiraz N
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
    Silvanose CD; Bailey TA; Di Somma A
    Vet Rec; 2006 Aug; 159(9):282-4. PubMed ID: 16946311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions.
    Perkhofer S; Jost D; Dierich MP; Lass-Flörl C
    Antimicrob Agents Chemother; 2008 May; 52(5):1873-5. PubMed ID: 18347112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.